{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-112420","form_type":"8-K","ticker":"LQDA","cik":"0001819576","company_name":"Liquidia Corp","filed_at":"2026-09-30T21:27:08+00:00","discovered_at":"2026-09-30T21:28:00.293953+00:00","generated_at":"2026-10-12T14:11:17.753908+00:00","sec_items":["8.01","9.01"],"event_type":"litigation","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Liquidia says Delaware court ruled claims 1 and 14 of United Therapeutics' '327 patent valid and infringed","bullets":["District Court for the District of Delaware found claims 1 and 14 of U.S. Patent No. 11,826,327 valid and infringed by Liquidia's YUTREPIA; remaining asserted claims were held invalid","Parties must submit a proposed form of judgment specifying remedies within one week; United Therapeutics (UTHR) has sought injunctive relief restricting YUTREPIA's market availability","CEO Roger Jeffs said Liquidia disagrees and will pursue all appellate options; the company plans an NDA supplement to remove the PH-ILD indication from YUTREPIA's label","Liquidia said it cannot reasonably estimate the range of outcomes or financial exposure; remedies could range from removing the PH-ILD indication to broader restrictions on product availability","Liquidia (LQDA) trades on Nasdaq; YUTREPIA was approved in 2025 for PAH and PH-ILD, and the press release was filed as Exhibit 99.1"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-112420","json":"https://secwatch.observer/filing/0001104659-26-112420.json","markdown":"https://secwatch.observer/filing/0001104659-26-112420.md","text":"https://secwatch.observer/filing/0001104659-26-112420.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819576/000110465926112420/0001104659-26-112420-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819576/000110465926112420/tm2626740d1_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T14:11:17.753908+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}